Description

Chonluten

Synthetic Tripeptide Bioregulator | Respiratory & Cellular Research Compound

Chonluten is an experimental synthetic short-peptide bioregulator associated with the Khavinson peptide research tradition. It is commonly identified in scientific and research sources as the tripeptide Glu-Asp-Gly (EDG), with a reported molecular weight of approximately 319.27 g/mol.

Chonluten has been investigated in experimental research involving bronchial and respiratory cellular biology, inflammatory signaling, cell proliferation, and immune-related pathways. Available evidence remains limited and is primarily based on laboratory and preclinical research rather than robust controlled human clinical trials.

Key Characteristics

  • Product Name: Chonluten
  • Common Sequence: Glu-Asp-Gly (EDG)
  • Peptide Length: 3 amino acids
  • Molecular Weight: Approximately 319.27 g/mol
  • Category: Synthetic tripeptide bioregulator
  • Research Areas: Respiratory biology, cellular signaling, inflammation, and peptide research
  • Research Stage: Experimental / primarily preclinical
  • Intended Use: Laboratory and analytical research

Research Profile

Chonluten has been examined as a short peptide associated with respiratory-tissue and immune-cell research. A 2022 study examining several Khavinson peptides included Chonluten in experiments using the THP-1 monocyte/macrophage cell model to investigate effects on proliferative activity and inflammatory pathways.

The available evidence suggests potential research relevance to pathways involving inflammatory signaling, cellular responses, and bronchial tissue biology, but the specific molecular mechanism of Chonluten is not fully established. Current evidence should therefore be considered exploratory rather than definitive.

Research Applications

Chonluten may be investigated in controlled laboratory research involving:

  • Bronchial and respiratory cell biology
  • Cellular signaling
  • Inflammatory pathway research
  • Monocyte and macrophage models
  • Cell-proliferation studies
  • Gene-expression research
  • Immune-response studies
  • Peptide structure–activity research
  • Peptide stability and characterization
  • Comparative short-peptide research

Research Advantages

Defined Tripeptide Structure

Provides a small, chemically defined peptide sequence suitable for controlled biochemical and cellular investigations.

Respiratory Research Utility

Offers a specialized research model for investigating cellular processes associated with bronchial and respiratory biology.

Immune-Cell Research

Has been incorporated into experimental studies using monocyte/macrophage models to investigate inflammatory and proliferative pathways.

Comparative Peptide Research

Can be studied alongside other short peptide bioregulators to evaluate sequence-dependent differences in cellular responses.

Analytical Characterization

The material can be analyzed for identity, purity, molecular mass, concentration, stability, and other relevant quality parameters.

Potential Research Areas

Research applications may include:

  • Respiratory epithelial biology
  • Bronchial-cell research
  • Inflammatory signaling
  • Immune-cell studies
  • Cellular proliferation
  • Gene-expression analysis
  • Peptide–cell interactions
  • Structure–activity relationship research
  • Stability and formulation studies
  • Analytical peptide characterization

Product Specifications

Specification Details
Product Name Chonluten
Sequence Glu-Asp-Gly (EDG)
Peptide Length 3 amino acids
Molecular Weight ~319.27 g/mol
Category Synthetic tripeptide
Research Stage Experimental / primarily preclinical
Application Laboratory & analytical research
Documentation Batch-specific COA recommended

Quality & Documentation

For legitimate research applications, batch-specific documentation should ideally confirm:

  • Exact peptide identity
  • Amino-acid sequence
  • Purity/assay
  • Molecular-weight confirmation
  • Peptide content
  • Batch or lot number
  • Certificate of Analysis (COA)
  • Stability information
  • Relevant analytical testing

Because commercial sources sometimes report different sequences or formulations under the Chonluten name, the exact material should be verified from the supplier’s analytical documentation before making sequence-specific claims.

Important Disclaimer

Chonluten is an experimental research peptide and should not be presented as an established treatment for asthma, COPD, bronchitis, respiratory infection, inflammation, or other medical conditions.

This product is intended strictly for laboratory research and analytical purposes and is not intended for human or veterinary consumption, diagnosis, treatment, prevention, or mitigation of disease. The available evidence is limited, and there is no robust controlled clinical evidence establishing safety and efficacy for human therapeutic use.